News Outlets Examine Various Aspects Of Research, Development Of Novel Coronavirus Vaccine

Bloomberg: Glaxo and Sanofi Are Discussing $620 Million U.K. Vaccine Deal (Paton, 7/5).

NPR: The Ethics Of Coronavirus Vaccine Trials In Developing Countries (Pfeiffer, 7/4).

NPR: How Much Would Coronavirus Vaccine Cost? (Garcia/Hirsch, 7/3).

Reuters: Britain nears $625 million Sanofi/GSK COVID-19 vaccine deal: report (Smout et al., 7/5).

Science: The line starts to form for a coronavirus vaccine (Cohen, 7/3).

VOA News: Health Authorities Aim to Build Alternative to COVID-19 Nationalism (Baragona, 7/5).

Wall Street Journal: Coronavirus Researchers Compete to Enroll Subjects for Vaccine Tests (Hopkins/Loftus, 7/5).

Washington Post: Elegant but unproven, RNA experiments leap to the front in coronavirus vaccine race. Will they work? (Booth/Johnson, 7/5).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.